HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sreenivas Gannavaram Selected Research

Leishmaniasis Vaccines

11/2021From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection.
1/2021Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis.
1/2016Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs.
1/2014Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sreenivas Gannavaram Research Topics

Disease

14Leishmaniasis
04/2022 - 01/2011
12Infections
04/2022 - 04/2013
12Visceral Leishmaniasis (Kala Azar)
01/2021 - 04/2013
5Parasitic Diseases (Parasitic Disease)
01/2022 - 01/2016
2Cutaneous Leishmaniasis
03/2022 - 01/2016
2Bites and Stings (Sting)
01/2022 - 01/2021
1Hypersensitivity (Allergy)
01/2021
1Asymptomatic Infections
01/2017
1Parasitemia
01/2017
1Asymptomatic Diseases
01/2017
1Virus Diseases (Viral Diseases)
01/2016
1Malaria
01/2014
1Human Influenza (Influenza)
01/2014
1Yellow Fever
01/2014

Drug/Important Bio-Agent (IBA)

18VaccinesIBA
04/2022 - 01/2012
4Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
03/2022 - 01/2016
4Leishmaniasis VaccinesIBA
11/2021 - 01/2014
3Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2014
3CytokinesIBA
01/2019 - 01/2016
2AntigensIBA
01/2021 - 01/2019
2Interleukin-12 (IL 12)IBA
01/2021 - 01/2019
2MicroRNAs (MicroRNA)IBA
01/2019 - 01/2017
1Interleukin-10 (Interleukin 10)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1leishmaninIBA
01/2021
14-O-carboxymethylascochlorinIBA
12/2020
1EpitopesIBA
01/2017
1Peptides (Polypeptides)IBA
01/2017
1Salivary Proteins and PeptidesIBA
01/2016
1Attenuated VaccinesIBA
06/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1Synthetic Vaccines (Recombinant Vaccines)IBA
04/2013
1Pharmaceutical PreparationsIBA
01/2011

Therapy/Procedure

1Intradermal Injections
01/2021
1Therapeutics
01/2017